HPQ Silicon subsidiary's hydrogen technology advances
HPQ Silicon Inc.'s subsidiary Novacium has reached a major milestone with its METAGENE™ hydrogen production technology. Lab results support patent application progress, and defense partners are considering funding for an industrial pilot plant.
HPQ Silicon Inc. announced significant advancements for its METAGENE™ hydrogen production technology, developed by its French affiliate Novacium SAS. The system generates hydrogen through a hydrolysis process.
The proprietary technology harnesses hydrogen released from low-cost, low-carbon metallic alloys via hydrolysis. This establishes an autonomous, on-demand pressurized energy process. Lab-scale pilot test results have strengthened the patent application before its progression to the PCT national phase and achieving 'Patent Pending' status.
Patent examiners have highlighted the technology's unique innovation and robustness with no prior art, a rare occurrence. The technology's simplicity and safety potential, utilizing a non-explosive and non-hazardous consumable energy source, have garnered interest. This contrasts with traditional processes relying on highly explosive fossil fuels or metallic powders.
Institutional and industrial partners within the European defense sector have pre-selected the project and are considering funding up to 75% of the €1 million cost for manufacturing an industrial-scale pilot plant. HPQ also holds an exclusive North American license for the METAGENE™ technology.
Novacium's METAGENE™ offers an alternative to traditional, capital-intensive, and often carbon-emitting hydrogen production methods like electrolysis and steam methane reforming, which require extensive infrastructure and electricity.